Paperpal Prime Logo

Clinical and Experimental Pharmacology and Physiology : Impact Factor & More

eISSN: 1440-1681pISSN: 0305-1870

Key Metrics

CiteScore
4.6
Impact Factor
< 5
SNIP
0.69
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Clinical and Experimental Pharmacology and Physiology

Clinical and Experimental Pharmacology and Physiology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1974
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Clinical and Experimental Pharmacology and Physiology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Clinical and Experimental Pharmacology and Physiology

Targeting of Pentraxin 3 Alleviated Cardiac Hypertrophy in Mice Induced by Angiotensin II
  • 1 Aug 2026
  • Clinical and Experimental Pharmacology & Physiology
Issue Information
  • 1 Aug 2026
  • Clinical and Experimental Pharmacology and Physiology
Relationship Between Long-Term Exposure to Airborne Particulate Matter and the Intrinsic Capacity of Middle-Aged and Older Adults in China: A Retrospective Cohort Study Based on CHARLS.
  • 1 Jul 2026
  • Clinical and experimental pharmacology & physiology
Electroacupuncture Alleviates Focal Cerebral Ischemia-Reperfusion Injury and Is Associated With Modulation of Autophagy-Ferroptosis Involving the STAT3/HIF-1α Signalling Pathway.
  • 1 Jul 2026
  • Clinical and experimental pharmacology & physiology
Bosutinib Inhibits USP9X to Suppress the Proliferation, Migration, Angiogenesis and Glycolysis of Hepatocellular Carcinoma Cells by Deubiquitinating PLK1.
  • 1 Jul 2026
  • Clinical and experimental pharmacology & physiology
Dapagliflozin Improves Mitochondrial Function to Reduce the Risk of Atrial Fibrillation in a High-Glucose Environment by Activating the AMPK/PGC-1α/SIRT3 Signalling Pathway.
  • 1 Jul 2026
  • Clinical and experimental pharmacology & physiology
Targeting of Pentraxin 3 Alleviated Cardiac Hypertrophy in Mice Induced by Angiotensin II
  • 1 Aug 2026
  • Clinical and Experimental Pharmacology & Physiology
Issue Information
  • 1 Aug 2026
  • Clinical and Experimental Pharmacology and Physiology
Relationship Between Long-Term Exposure to Airborne Particulate Matter and the Intrinsic Capacity of Middle-Aged and Older Adults in China: A Retrospective Cohort Study Based on CHARLS.
  • 1 Jul 2026
  • Clinical and experimental pharmacology & physiology
Electroacupuncture Alleviates Focal Cerebral Ischemia-Reperfusion Injury and Is Associated With Modulation of Autophagy-Ferroptosis Involving the STAT3/HIF-1α Signalling Pathway.
  • 1 Jul 2026
  • Clinical and experimental pharmacology & physiology
Bosutinib Inhibits USP9X to Suppress the Proliferation, Migration, Angiogenesis and Glycolysis of Hepatocellular Carcinoma Cells by Deubiquitinating PLK1.
  • 1 Jul 2026
  • Clinical and experimental pharmacology & physiology
Dapagliflozin Improves Mitochondrial Function to Reduce the Risk of Atrial Fibrillation in a High-Glucose Environment by Activating the AMPK/PGC-1α/SIRT3 Signalling Pathway.
  • 1 Jul 2026
  • Clinical and experimental pharmacology & physiology

FAQs on Clinical and Experimental Pharmacology and Physiology